(Q34892662)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23914773%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

title

Local therapies for inflammatory eye disease in translation: past, present and future (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23914773%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23914773%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

author name string

Shenzhen Tempest-Roe

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23914773%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Lavnish Joshi

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23914773%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Andrew D Dick

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23914773%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

publication date

6 August 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23914773%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23914773%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23914773%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23914773%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

page(s)

39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23914773%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1186/1471-2415-13-39

6 March 2020

exact match

0 references

cites work

Intraocular methotrexate can induce extended remission in some patients in noninfectious uveitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3750406

Ocular tolerability and efficacy of intravitreal and subconjunctival injections of sirolimus in patients with non-infectious uveitis: primary 6-month results of the SAVE Study

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3750406

SIRT1 activation protects against autoimmune T cell-driven retinal disease in mice via inhibition of IL-2/Stat5 signaling

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3750406

Road to fulfilment: taming the immune response to restore vision

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3750406

A systematic review of the association of diabetic retinopathy and cognitive impairment in people with Type 2 diabetes

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3750406

Interplay between innate and adaptive immunity in the development of non-infectious uveitis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3750406

Difluprednate for inflammatory eye disorders

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3750406

Review and update of intraocular therapy in noninfectious uveitis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3750406

Randomized comparison of systemic anti-inflammatory therapy versus fluocinolone acetonide implant for intermediate, posterior, and panuveitis: the multicenter uveitis steroid treatment trial

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3750406

Understanding uveitis: the impact of research on visual outcomes

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3750406

Cytomegalovirus endotheliitis after fluocinolone acetonide (Retisert) implant in a patient with Behçet uveitis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3750406

Long-term, multicenter evaluation of subconjunctival injection of triamcinolone for non-necrotizing, noninfectious anterior scleritis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3750406

Ocular neuroprotection by siRNA targeting caspase-2

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3750406

What is new HLA-B27 acute anterior uveitis?

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3750406

Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3750406

Cryopyrin-associated periodic syndrome: an update on diagnosis and treatment response

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3750406

New developments in corticosteroid therapy for uveitis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3750406

Sustained ocular delivery of fluocinolone acetonide by an intravitreal insert

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3750406

Nonsteroidal anti-inflammatory drugs in ophthalmology

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3750406

Comparison of orbital floor triamcinolone acetonide and oral prednisolone for cataract surgery management in patients with non-infectious uveitis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3750406

The NLRP3 inflammasome: a sensor for metabolic danger?

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3750406

More questions than answers: a call for a moratorium on the use of intravitreal infliximab outside of a well-designed trial

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3750406

Adverse events after intravitreal infliximab (Remicade).

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3750406

The use of intraocular corticosteroids

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3750406

P2X7 deficiency attenuates renal injury in experimental glomerulonephritis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3750406

Penetration of topical and subconjunctival corticosteroids into human aqueous humour and its therapeutic significance.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3750406

Assessment: the use of natalizumab (Tysabri) for the treatment of multiple sclerosis (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3750406

Orbital floor triamcinolone acetonide injections for the management of active non-infectious uveitis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3750406

International Uveitis Study Group (IUSG): clinical classification of uveitis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3750406

Advances in the diagnosis and immunotherapy for ocular inflammatory disease

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3750406

Tumor necrosis factor antagonists: preliminary evidence for an emerging approach in the treatment of ocular inflammation

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3750406

Ranibizumab versus verteporfin for neovascular age-related macular degeneration.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3750406

Ranibizumab for neovascular age-related macular degeneration

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3750406

Intravitreal injection of Tacrolimus (FK506) suppresses ongoing experimental autoimmune uveoretinitis in Rats

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3750406

Efficacy of low-release-rate fluocinolone acetonide intravitreal implants to treat experimental uveitis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3750406

The pros and cons of intravitreal triamcinolone injections for uveitis and inflammatory cystoid macular edema.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3750406

Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3750406

A review of evidence guiding the use of corticosteroids in the treatment of intraocular inflammation

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3750406

Intravitreal dexamethasone effectively reduces postoperative inflammation after vitreoretinal surgery

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3750406

The danger model: a renewed sense of self

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3750406

Developments in the treatment of uveitis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3750406

Randomized clinical trial of Surodex steroid drug delivery system for cataract surgery: anterior versus posterior placement of two Surodex in the eye.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3750406

From beach to bedside: history of the development of sirolimus

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3750406

Phase II results of an intraocular steroid delivery system for cataract surgery

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3750406

Randomized clinical trial of a new dexamethasone delivery system (Surodex) for treatment of post-cataract surgery inflammation

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3750406

Interleukin 6 induces the expression of vascular endothelial growth factor

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3750406

Local cyclosporine therapy for experimental autoimmune uveitis in rats

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3750406

Efficacy and safety of 1% rimexolone versus 1% prednisolone acetate in the treatment of anterior uveitis--a randomized triple masked study

8 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2415-13-39

Clinical trial to compare efficacy and side-effects of injection of posterior sub-Tenon triamcinolone versus orbital floor methylprednisolone in the management of posterior uveitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2415-13-39

Characterisation of systemic and ocular drug level of triamcinolone acetonide following a single sub-Tenon injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2415-13-39

Complications and safety profile of posterior subtenon injection of triamcinolone acetonide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2415-13-39

Intravitreal and orbital floor triamcinolone acetonide injections in noninfectious uveitis: a comparative study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2415-13-39

Intravitreal dexamethasone as adjuvant in the treatment of postoperative endophthalmitis: a prospective randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2415-13-39

Vitreous concentrations of triamcinolone acetonide in human eyes after intravitreal or subtenon injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2415-13-39

Intravitreal triamcinolone for persistent cystoid macular oedema in eyes with quiescent uveitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2415-13-39

Effect of the macromolecular architecture of biodegradable polyurethanes on the controlled delivery of ocular drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2415-13-39

Ocular pharmacokinetics of fluocinolone acetonide after Retisert intravitreal implantation in rabbits over a 1-year period

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2415-13-39

Combined fluocinolone acetonide intravitreal insertion and glaucoma drainage device placement for chronic uveitis and glaucoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2415-13-39

Combined fluocinolone acetonide intraocular delivery system insertion, phacoemulsification, and intraocular lens implantation for severe uveitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2415-13-39

Pilot study of intravitreal injection of diclofenac for treatment of macular edema of various etiologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2415-13-39

Intravitreal methotrexate as an adjunctive treatment of intraocular lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2415-13-39

Intraocular methotrexate in the treatment of uveitis and uveitic cystoid macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2415-13-39

Cyclosporine-loaded microspheres for treatment of uveitis: in vitro characterization and in vivo pharmacokinetic study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2415-13-39

Effects of intravitreal injection of tacrolimus (FK506) in experimental uveitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2415-13-39

Intravitreal VEGF levels in uveitis patients and treatment of uveitic macular oedema with intravitreal bevacizumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2415-13-39

Intravitreal bevacizumab (avastin) as a treatment for refractory macular edema in patients with uveitis: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2415-13-39

Ranibizumab for refractory uveitis-related macular edema.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2415-13-39

Short-term results of a single intravitreal bevacizumab (avastin) injection versus a single intravitreal triamcinolone acetonide (kenacort) injection for the management of refractory noninfectious uveitic cystoid macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2415-13-39

Intravitreal bevacizumab versus triamcinolone acetonide for refractory uveitic cystoid macular edema: a randomized pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2415-13-39

Infliximab for recurrent, sight-threatening ocular inflammation in Adamantiades-Behçet disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2415-13-39

Effect of infliximab on sight-threatening panuveitis in Behçet's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2415-13-39

Intravitreal infliximab for the treatment of sight-threatening chronic noninfectious uveitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2415-13-39

Evaluation of potential retinal toxicity of adalimumab (Humira).

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2415-13-39

Intravitreal adalimumab for refractory uveitis-related macular edema.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2415-13-39

Rapamune® (RAPA, rapamycin, sirolimus): mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2415-13-39

Fingolimod (FTY720) as an acute rescue therapy for intraocular inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2415-13-39

Rituximab is effective in the treatment of refractory ophthalmic Wegener's granulomatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2415-13-39

Combination intravitreal rituximab and methotrexate for massive subretinal lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2415-13-39

Pharmacokinetics and posterior segment biodistribution of ESBA105, an anti-TNF-alpha single-chain antibody, upon topical administration to the rabbit eye.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2415-13-39

Mathematical modeling of triamcinolone acetonide drug release from the I-vation intravitreal implant (a controlled release platform).

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3750406

Intravitreal triamcinolone for intraocular inflammation and associated macular edema

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3750406

Intravitreal bevacizumab in refractory uveitic macular edema: one-year follow-up.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3750406

Outcome of intravitreal triamcinolone in uveitis

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3750406

Blockade of nuclear factor-kappaB signaling inhibits angiogenesis and tumorigenicity of human ovarian cancer cells by suppressing expression of vascular endothelial growth factor and interleukin 8.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3750406

Dexamethasone Implant in Pediatric Uveitis

26 October 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2415-13-39

intravitreal tumor necrosis factor inhibitors in the treatment of refractory diabetic macular edema: a pilot study from the Pan-American Collaborative Retina Study Group

21 January 2018

1 reference

12 December 2020

Topical application of ciclosporin ophthalmic solution containing alpha-cyclodextrin in experimental uveitis

1 reference

12 December 2020

Intravitreal bevacizumab for treatment of uveitic macular edema

1 reference

12 December 2020

Orbital floor steroid injections in the treatment of uveitis

1 reference

12 December 2020

Iluvien: a new sustained delivery technology for posterior eye disease

1 reference

12 December 2020

Intravitreal ketorolac for chronic uveitis and macular edema: a pilot study

1 reference

12 December 2020

Safety profile of intravitreal triamcinolone acetonide

1 reference

12 December 2020

The effects of posterior subtenon injection of triamcinolone acetonide in patients with intermediate uveitis

1 reference

12 December 2020

Intraocular penetration of periocular ketorolac and efficacy in experimental uveitis

1 reference

12 December 2020

Intraocular methotrexate in ocular diseases other than primary central nervous system lymphoma

1 reference

12 December 2020

Controlled evaluation of loteprednol etabonate and prednisolone acetate in the treatment of acute anterior uveitis. Loteprednol Etabonate US Uveitis Study Group

1 reference

12 December 2020

Rituximab in refractory ophthalmic Wegener's granulomatosis: PR3 titers may predict relapse, but repeat treatment can be effective

1 reference

12 December 2020

Role of intravitreal methotrexate in the management of primary central nervous system lymphoma with ocular involvement

1 reference

12 December 2020

Aqueous humor and plasma vascular endothelial growth factor in uveitis-associated cystoid macular edema

1 reference

12 December 2020

Distinct cytokine and chemokine profiles in the aqueous of patients with uveitis and cystoid macular edema

1 reference

12 December 2020

Intravitreal methotrexate in uveitis

1 reference

12 December 2020

Repeat intravitreal triamcinolone acetonide injections in uveitic macular oedema

1 reference

12 December 2020

Infliximab for chronic cystoid macular edema associated with uveitis

1 reference

12 December 2020

Efficacy and safety of intravitreal bevacizumab compared with intravitreal and posterior sub-tenon triamcinolone acetonide for treatment of uveitic cystoid macular edema

1 reference

12 December 2020

Fluocinolone acetonide implant (Retisert) for noninfectious posterior uveitis: thirty-four-week results of a multicenter randomized clinical study

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2415-13-39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23914773%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

6 March 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23914773%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23914773%20AND%20SRC:MED&resulttype=core&format=json